Genprex, Inc.
GNPX
$2.83
$0.093.29%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -26.38% | -55.00% | -47.45% | -33.52% | -50.54% |
| Depreciation & Amortization | -- | -- | -- | -85.29% | -64.86% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.61% | -28.17% | -33.81% | -27.35% | -44.47% |
| Operating Income | 22.61% | 28.17% | 33.81% | 27.35% | 44.47% |
| Income Before Tax | 11.97% | 28.03% | 33.58% | 22.29% | 44.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.97% | 28.03% | 33.58% | 22.29% | 44.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.97% | 28.03% | 33.58% | 22.29% | 44.30% |
| EBIT | 22.61% | 28.17% | 33.81% | 27.35% | 44.47% |
| EBITDA | 22.63% | 28.18% | 33.81% | 27.32% | 44.46% |
| EPS Basic | 91.90% | 94.36% | 93.27% | 86.76% | 77.00% |
| Normalized Basic EPS | 91.90% | 94.36% | 92.96% | 87.56% | 77.00% |
| EPS Diluted | 91.90% | 94.36% | 93.27% | 86.76% | 77.00% |
| Normalized Diluted EPS | 91.90% | 94.36% | 92.96% | 87.56% | 77.00% |
| Average Basic Shares Outstanding | 986.43% | 1,177.55% | 842.28% | 487.88% | 142.21% |
| Average Diluted Shares Outstanding | 986.43% | 1,177.55% | 842.28% | 487.88% | 142.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |